A phase I clinical study of the antipurine antifolate lometrexol (DDATHF) given with oral folic acid.
Laohavinij S, Wedge SR, Lind MJ, Bailey N, Humphreys A, Proctor M, Chapman F, Simmons D, Oakley A, Robson L, Gumbrell L, Taylor GA, Thomas HD, Boddy AV, Newell DR, Calvert AH.
Laohavinij S, et al. Among authors: calvert ah.
Invest New Drugs. 1996;14(3):325-35. doi: 10.1007/BF00194536.
Invest New Drugs. 1996.
PMID: 8958188
Clinical Trial.